Related Experiment Video
Updated: Jul 12, 2026
10:25
Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection
Published on: June 5, 2021
SARS-CoV-2 prevalence and immunity: a hospital-based study from Malawi
Summary
COVID-19 (Coronavirus Disease 2019) transmission in Malawi is likely underestimated. Hospital-based surveillance revealed a 10.1% prevalence, with many asymptomatic cases, and feasible immunity estimation using surrogate virus neutralization tests (sVNTs).
Area of Science:
- Epidemiology
- Infectious Diseases
- Public Health
Background:
- COVID-19 (Coronavirus Disease 2019) transmission and disease dynamics in sub-Saharan Africa remain poorly understood.
- Limited data exists on SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) epidemiology in Malawi.
- Hospital-based settings offer a unique perspective for assessing disease prevalence and immunity.
Purpose of the Study:
- To estimate SARS-CoV-2 prevalence in Lilongwe, Malawi.
- To assess SARS-CoV-2 immunity in a hospital-based cohort.
- To provide insights into COVID-19 epidemiology in sub-Saharan Africa.
Main Methods:
- Cross-sectional survey using convenience sampling in Lilongwe, Malawi.
- SARS-CoV-2 testing via enzyme-linked immunosorbent assay and RT-PCR (Reverse-Transcription Polymerase Chain Reaction).
- Surrogate virus neutralization test (sVNT) for immunity assessment in seropositive individuals; Poisson regression for prevalence analysis.
Main Results:
- A combined point prevalence of 10.1% was observed in 930 participants.
- RT-PCR positivity was 2.0%, seropositivity was 9.3%, and 90.1% of seropositive samples showed sVNT positivity.
- A high rate of asymptomatic SARS-CoV-2 infection (45.7%) was detected, with prevalence significantly associated with healthcare worker status.
Conclusions:
- Official COVID-19 data likely underestimates actual transmission in Malawi.
- sVNTs are a feasible method for estimating post-infection immunity in this setting.
- Subclinical infections play a significant role in surveillance, mitigation, and vaccination strategies.
Related Concept Videos
01:05Single Nucleotide Polymorphisms-SNPs
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
01:29Coronavirus
Coronaviruses, including the severe acute respiratory syndrome coronavirus (SARS-CoV), are enveloped viruses characterized by their single-stranded, positive-sense RNA genome and helical nucleocapsid structure. The hallmark of these viruses is their club-shaped spike (S) glycoproteins that protrude from the viral envelope, facilitating attachment to host cells. Typically, coronaviruses infect the upper respiratory tract, often causing mild or asymptomatic disease. However, certain strains like...